Evidence map›Paper›PMID 29795662›Full record

ArticlePloS one2018

Identification of peculiar gene expression profile in peripheral blood mononuclear cells (PBMC) of celiac patients on gluten free diet.

Moris Sangineto, Giusi Graziano, Simona D'Amore, Roberto Salvia, Giuseppe Palasciano, Carlo Sabbà, Michele Vacca, Marica Cariello

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The expression levels of CHI3L1 and IL15Rα correlate with TGM2 in duodenum biopsies of patients with celiac disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Article
  11. Article
  12. Effects ofFrontiers in immunology · 2020
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Moris SanginetoDepartment of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.
Giusi GrazianoNational Cancer Research Center, IRCCS Oncologico Giovanni Paolo II, Bari, Italy.
Simona D'AmoreDepartment of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.
Roberto SalviaDepartment of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.
Giuseppe PalascianoDepartment of Biomedical Sciences and Human Oncology, Clinica Medica "A. Murri", "Aldo Moro" University of Bari, Bari, Italy.
Carlo SabbàDepartment of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.
Michele VaccaDepartment of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.
Marica CarielloDepartment of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.ORCID 0000-0002-7537-6657
University of Bari Aldo Moro · ITIstituto Nazionale Biostrutture e Biosistemi · ITIstituto Tumori Bari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Celiac disease (CD) is a systemic disorder characterized by an immune-mediated reaction to gluten and a wide spectrum of clinical manifestations. Currently, the main treatment of CD is represented by adherence to a gluten-free diet (GFD) which determines the resolution of symptoms, and the normalization of the serology and of the duodenal villous atrophy. In the present study, we aimed to identify changes in gene expression in peripheral blood mononuclear cells (PBMCs) of celiac patients on GFD for at least 2 years, in order to identify novel disease biomarkers and candidate targets for putative therapeutic approaches. Microarray analysis was performed on PBMCs from 17 celiac patients on long-term GFD and 20 healthy controls. We identified 517 annotated genes that were significantly modulated between celiac patients and controls. Significant biological pathways were functionally clustered using the Core Function of Ingenuity System Pathway Analysis (IPA). Intriguingly, despite being on a GFD, celiac patients exhibited a peculiar PBMC profile characterized by an aberrant expression of genes involved in the regulation of immunity, inflammatory response, metabolism, and cell proliferation. Random forest algorithm was then used to validate the prediction ability of core genes as classifiers of the "celiac status". In conclusion, our study identified a characteristic PBMCs signature profile in clinically asymptomatic celiac patient.

Indexed as

Diet, Gluten-FreeAdultCeliac DiseaseFemaleGene Expression ProfilingGene Expression RegulationHumansLeukocytes, MononuclearMaleMicroarray AnalysisTranscriptome

Identifiers

PMID29795662
PMCPMC5967809
OpenAlexW2804577455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.